Search NLS News

In her new role as Chief Executive Officer at Medicon Valley Alliance, Anette Steenberg aims to zoom in on the strongholds of the region as well as strengthening the framework conditions for life sciences across Øresund. Medicon Valley Alliance (MVA), founded in 1997, is a non-profit membership organization in the Danish-Swedish life science cluster Medicon […]

Oncorena has announced that Börje Haraldsson has joined the management team as Chief Scientific Officer. Professor Haraldsson, is one of the founders of Oncorena. Being a world leader in clinical and experimental renal research, he will bring a wealth of clinical experience and competence to the company, states the company. “It is truly a great […]

The Board of Dignitana AB appoints Catarina Mård Löwenadler as the new CEO of Dignitana. Mård Löwenadler has extensive experience from leading positions in both medtech and sales and will take over as CEO at the Annual General Meeting in May, states the company. Magnus Blixt, who was previously appointed CEO, chose not to take […]

Recipharm has announced the acquisition of GenIbet, a Portuguese CDMO, specializing in the manufacture of biological clinical trial material and novel modalities such as viral vectors, RNA and microbiome. The acquisition forms part of Recipharm’s strategy to grow in the biologics market, with a particular focus on drug substance manufacturing of novel ATMPs, the company […]

Martin Nicklasson has been elected new chairman of Nykode Therapeutics as the company enters a new stage of internationalization. “I am delighted to join Nykode Therapeutics as new chairman. I am extremely impressed by the company’s technology platform and R&D pipeline, as well as the company’s outstanding achievements, including closing three landmark collaboration agreements over […]

Oncorena has announced the initiation of the Phase I-II clinical trial of orellanine in patients with advanced kidney cancer on dialysis. The drug candidate orellanine is being developed for organ-specific chemotherapy with curative potential for patients with advanced kidney cancer undergoing dialysis due to kidney failure. Preclinical evidence shows that orellanine specifically exerts powerful anti-tumor […]

BioInvent International has announces that its anti-FcyRllB antibody BI-1206 has been granted Orphan Drug Designation by the U.S. Food and Drug Administration for the treatment of follicular lymphoma, the most common form of slow-growing Non-Hodgkin lymphoma. BI-1206 previously received ODD from the FDA for the treatment of mantle cell lymphoma (MCL) in January 2019. BI-1206 […]

University of Copenhagen (UCPH) and Eir Ventures, a life science focused venture fund, have established a limited company with the main aim of investing in the University’s own spin-out companies. It is the first time that a Danish university establishes an investment company of this kind. UCPH Ventures The newly-established investment company, UCPH Ventures, will […]

BerGenBio and Oslo University Hospital have announced the execution of a collaborative agreement to study the BerGenBio AXL inhibitor bemcentinib, in hospitalised COVID-19 patients. The EU-SolidAct trial – European DisCoVeRy for Solidarity: An Adaptive Pandemic and Emerging Infection Platform Trial – is part of EU-RESPONSE, a pan-European research project involved with the rapid and coordinated […]

Capitainer has announced that Donald H. Chace has been appointed as Capitainer representative for North Americas. Bringing experience covering Neonatology, Clinical Chemistry, Newborn Screening, Mass Spectrometry and Forensic Science, he joins the team as Capitainer looks to penetrate the US market with their qDBS dried blood sampling technology, it states. “We are delighted to welcome […]